Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FTO: FYSIOTERAPI -TRÆNING - ODENSE I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.7% 3.0% 3.0% 3.0% 3.2% 2.9% 6.5% 6.5%   Credit score (0-100)   53 57 56 57 55 59 37 37   Credit rating   BBB BBB BBB BBB BBB BBB BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   10,994 9,719 9,658 10,680 11,601 11,988 0.0 0.0   EBITDA   1,047 1,992 3,068 3,148 4,220 4,118 0.0 0.0   EBIT   290 1,273 2,408 2,739 3,877 3,660 0.0 0.0   Pre-tax profit (PTP)   -963.8 45.7 1,224.6 1,551.9 1,776.9 1,239.8 0.0 0.0   Net earnings   -963.8 45.7 1,224.6 1,551.9 1,776.9 1,239.8 0.0 0.0   Pre-tax profit without non-rec. items   -964 45.7 1,225 1,552 1,777 1,240 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   25,261 24,912 24,622 24,389 24,173 24,011 0.0 0.0   Shareholders equity total   500 500 500 500 500 500 0.0 0.0   Interest-bearing liabilities   30,197 28,801 26,827 25,049 23,715 23,617 3,725 3,725   Balance sheet total (assets)   32,214 31,783 30,260 29,565 29,241 28,868 3,725 3,725   Net Debt   30,180 28,780 26,740 25,047 23,673 23,615 3,725 3,725     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   10,994 9,719 9,658 10,680 11,601 11,988 0.0 0.0   Gross profit growth   39.3% -11.6% -0.6% 10.6% 8.6% 3.3% -100.0% 0.0%   Employees   25 20 15 15 16 16 0 0   Employee growth %   66.7% -20.0% -25.0% 0.0% 6.7% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   32,214 31,783 30,260 29,565 29,241 28,868 3,725 3,725   Balance sheet change%   0.0% -1.3% -4.8% -2.3% -1.1% -1.3% -87.1% 0.0%   Added value   1,046.8 1,991.8 3,067.5 3,148.3 4,286.8 4,118.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,705 -1,438 -1,318 -819 -488 -917 -24,011 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   2.6% 13.1% 24.9% 25.6% 33.4% 30.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.9% 4.0% 7.8% 9.2% 13.2% 12.6% 0.0% 0.0%   ROI %   1.0% 4.2% 8.5% 10.4% 15.6% 15.1% 0.0% 0.0%   ROE %   -192.8% 9.1% 244.9% 310.4% 355.4% 248.0% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   1.6% 1.6% 1.7% 1.7% 1.7% 1.7% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   2,883.2% 1,444.9% 871.7% 795.6% 560.9% 573.4% 0.0% 0.0%   Gearing %   6,039.4% 5,760.2% 5,365.3% 5,009.9% 4,743.0% 4,723.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.4% 4.2% 4.3% 4.6% 8.6% 10.2% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.3 0.4 0.2 0.1 0.1 0.1 0.0 0.0   Current Ratio   0.3 0.3 0.2 0.1 0.1 0.1 0.0 0.0   Cash and cash equivalent   17.3 20.9 87.1 2.5 42.0 2.3 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -4,132.2 -4,453.9 -6,371.0 -7,000.1 -7,388.6 -7,790.6 -1,862.3 -1,862.3   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   42 100 205 210 268 257 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   42 100 205 210 264 257 0 0   EBIT / employee   12 64 161 183 242 229 0 0   Net earnings / employee   -39 2 82 103 111 77 0 0